VAXIMM Reports Positive Follow-On Data from Oral Cancer Vaccine Trial
VAXIMM AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced today follow-on data from the firs…
VAXIMM AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced today follow-on data from the firs…
VAXIMM AG, a Swiss-German biotech firm and Merck KGaA spin-off, announced today the start of the first clinical trial of…
Swiss biotech firm and Merck KGaA spin-off VAXIMM AG announced today the closing of a private financing round totaling C…